David Rossini
Impact in
- Pharmacology top 2%
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
- Neurology top 5%
- Transcranial Magnetic Stimulation Studies
Papers in
- Pharmacology 11
- Treatment of Major Depression 11
-
- Transcranial Magnetic Stimulation Studies 5
- Co-authors
- Raffaella Zanardi (19 shared papers)Enrico Smeraldi (12 shared papers)Alessandro Serretti (12 shared papers)Cristina Cusin (7 shared papers)Cristina Lorenzi (6 shared papers)Lorenzo Magri (5 shared papers)Adelio Lucca (5 shared papers)Enrico Lattuada (3 shared papers)
In The Last Decade
David Rossini
20 papers receiving 932 citations
Peers
Comparison fields: 5 of 44
- Pharmacology 420
- Neurology 205
- Pharmacology 226
- Cellular and Molecular Neuroscience 285
- Psychiatry and Mental health 139
Countries citing papers authored by David Rossini
This map shows the geographic impact of David Rossini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rossini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rossini more than expected).
Fields of papers citing papers by David Rossini
This network shows the impact of papers produced by David Rossini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rossini. The network helps show where David Rossini may publish in the future.
Co-authors
The 25 scholars most cited alongside David Rossini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 193 | |
| 2 | 2001 | 98 | |
| 3 | 2005 | 92 | |
| 4 | 2002 | 85 | |
| 5 | 2005 | 79 | |
| 6 | 2004 | 61 | |
| 7 | 2011 | 46 | |
| 8 | 2007 | 42 | |
| 9 | 2001 | 41 | |
| 10 | 2004 | 41 | |
| 11 | 2005 | 35 | |
| 12 | 2006 | 34 | |
| 13 | 2003 | 30 | |
| 14 | 2009 | 27 | |
| 15 | 2003 | 23 | |
| 16 | 2007 | 22 | |
| 17 | 2000 | 15 | |
| 18 | 2008 | 4 | |
| 19 | 2013 | 4 | |
| 20 | 2010 | 3 |
About David Rossini
David Rossini is a scholar working on Pharmacology, Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Family Practice, having authored 20 papers that have together received 975 indexed citations. Recurring topics across this work include Treatment of Major Depression (11 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Transcranial Magnetic Stimulation Studies (5 papers), Bipolar Disorder and Treatment (2 papers), Electroconvulsive Therapy Studies (1 paper) and Medication Adherence and Compliance (1 paper). The work is most often cited by research in Pharmacology (420 citations), Neurology (205 citations), Pharmacology (226 citations), Cellular and Molecular Neuroscience (285 citations) and Psychiatry and Mental health (139 citations). David Rossini has collaborated with scholars based in Italy and Japan. Frequent co-authors include Raffaella Zanardi, Enrico Smeraldi, Alessandro Serretti, Cristina Cusin, Cristina Lorenzi, Lorenzo Magri, Adelio Lucca, Enrico Lattuada, Danilo Dotoli and L. Franchini. Their work appears in journals such as Psychiatry Research, Psychiatry and Clinical Neurosciences, European Neuropsychopharmacology, Journal of Clinical Psychopharmacology and Journal of Ect.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.